Author Interview: Professor Kevin Winthrop (January 2022)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

Discussing Rheumatology: HZ and ILD with tofacitinib in RA

Prof Iain McInnes reviews two papers this month, and discusses the risk of herpes zoster (HZ) events in patients with RA treated with tofacitinib, as well as interstitial lung disease, an extra-articular manifestation of RA.

Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA

Prof Iain McInnes reviews two papers this month, and discusses exposure-adjusted incidence rates of TEAEs and AESIs with filgotinib, as well as the efficacy and safety of tofacitinib in pJIA.

Author Interview: Professor Kevin Winthrop (December 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

Author Interview: Professor Kevin Winthrop (November 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA

Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis.